Predomination of proinflammatory TNF-α/IFN-γ-producing Th1 cells, besides enhancing CTL activity, also facilitates innate antitumor mechanisms and associates with the absence of metastatic invasion, tumor recurrence, and increased survival of patients with CRC [37–39]. The gene discussed is TNF; the disease is neoplasm.